Birmingham, AL, United States of America

Beverly Ann Layton


Average Co-Inventor Count = 10.6

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1999-2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Beverly Ann Layton: Innovator in Multiple Sclerosis Research

Introduction

Beverly Ann Layton is a distinguished inventor based in Birmingham, AL (US). She has made significant contributions to the field of medical research, particularly in understanding multiple sclerosis. With a total of 2 patents, her work focuses on innovative methods for diagnosing and monitoring this complex disease.

Latest Patents

Layton's latest patents include groundbreaking methods related to multiple sclerosis. One patent details a method for determining the status of a multiple sclerosis patient by measuring urinary p-cresol sulfate. This method can predict the transition from a relapsing-remitting phase to a progressive phase of the disease. Additionally, it provides a way to assess the amount of lesions and total lesion area in patients. Another patent outlines a method for measuring urinary myelin basic protein-like material, which serves a similar purpose in monitoring the disease's progression and myelination in developing children.

Career Highlights

Beverly Ann Layton is affiliated with the UAB Research Foundation, where she conducts her research. Her work has been pivotal in advancing the understanding of multiple sclerosis and improving patient care through innovative diagnostic methods.

Collaborations

Layton has collaborated with notable colleagues, including John Nicholas Whitaker and Robert David Kachelhofer. These partnerships have enhanced her research efforts and contributed to the development of her patented methods.

Conclusion

Beverly Ann Layton's contributions to multiple sclerosis research through her patents and collaborations highlight her role as an innovator in the medical field. Her work continues to impact the lives of patients and advance scientific understanding of this challenging condition.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…